Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 3, 2006, Pages 288-292

  Lachapelle, Jean Marie ^a   Decroix, J ^d   Henrijean, A ^d   Roquet Gravy, P P ^d   De Swerdt, A ^b   Boonen, H ^d   Lecuyer, M ^d   Suys, E ^d   Speelman, G ^d   Vastesaeger, N ^c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Schering Plough   (Belgium)

^d NONE

Author keywords

Chronic idiopatic urticaria; Desloratadine; Once daily; Quality of life

Indexed keywords

DESLORATADINE;

ADULT; ARTICLE; BELGIUM; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEADACHE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SCORING SYSTEM; SEDATION; SOMNOLENCE; TREATMENT OUTCOME; URTICARIA; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; BELGIUM; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LORATADINE; MALE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URTICARIA;

EID: 33645981589     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01429.x     Document Type: Article

References (18)

1. Strachan D. Chronic urticaria. [WWW document] 2005. URL http://www.emedicine.com/derm/topic443.htm (last accessed: January 2006).
2. Sheikh J. Urticaria. [WWW document] 2004. URL http://www.emedicine.com/med/topic3014.htm (last accessed: January 2006).
3. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
4. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140: 667-671.
5. Lee EE, Maibach HI. Treatment of urticaria: An evidence-based evaluation of antihistamines. Am J Clin Dermatol 2001; 2: 27-32.
6. Joint Task Force on Practice Parameters. The diagnosis and management of urticaria: A practice pArameter part I: Acute urticaria/angioedema part II: Chronic urticaria/angioedema. Ann Allergy Asthma Immunol 2000; 85: 521-544.
7. Zuberbier T, Greaves MW, Juhlin L et al. Definition, classification and routine diagnosis of urticaria: A consensus report. J Invest Dermatol Symp Proc 2001; 6: 123-127.
8. Ortonne JP. Chronic idiopathic urticaria for the generalist. Eur J Intern Med 2003; 14: 148-157.
9. Ring J, Hein R, Gauger A, Bronsky E, Miller B. Once- daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: A randomized, double- blind, placebo-controlled study. Int J Dermatol 2001; 40: 72-76.
10. Monroe E, Finn A, Patel P et al. Desloratadine Urticaria Study Group. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol 2003; 48: 535-541.
11. Thompson AK, Finn AF, Schoenwetter WF. Effect of 60 mg twice-daily fexofenadine HCI on quality of life, work and classroom productivity, and regular activity in patients with chronic idiopathic urticaria. J Am Acad Dermatol 2000; 43: 24-30.
12. Geha RS, Meltzer EO. Desloratadine: A new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001; 107: 751-762.
13. Hey JA, Barnett A, Iorio L, Chiu P, Kreutner W. Desloratadine: Cardiovascular, central nervous system, renal and gastrointestinal safety profile of this nonsedating H1 antihistamine. Allergy 2000; 55: abstract 996.
14. Rikken G, Danzig MB, Staudinger H. Desloratadine and alcohol co-administration: No increase impairment of performance over that induced by alcohol alone. Allergy 2000; 55: Abstract 993.
15. Vuurman E, Ramaekers JG, Rikken G, de Halleux F. Desloratadine does not impair actual driving performance: A 3-way cross-over comparison with diphenhydramine and placebo. Allergy 2000; 55: Abstract 996.
16. Ring J, Gauger A, Hein R. Clinical efficacy of desloratadine in chronic urticaria. Clin Drug Invest 2002; 22: 33-41.
17. Yosipovitch G, Ansari N, Goon A, Chan YH, Goh CL. Clinical characteristics of pruritus in chronic idiopathic urticaria. Br J Dermatol 2002; 147: 32-36.
18. Finlay AY, Khan GK. Dermatology Life Quality index (DLQI): A simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.